Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment

• Status: Recruiting
• Trial end date: 2022-03-23
• Target enrollment: 0
• Participant gender: All

Summary

In this case, series, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the PACU in ambulatory surgery patients taking Suboxone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Montefiore Medical Center
• Treatments: Dsuvia

Criteria

Inclusion Criteria:

• • Age range 18-100 years

• Currently taking Suboxone

• ASA physical score 1-3

• Able to provide a signed informed consent

• General anesthesia (either endotracheal intubation or laryngeal mask airway) without the use of regional anesthesia

Exclusion Criteria:

• • Known allergic reactions to Dsuvia and its excipients

• Severe respiratory illness including exacerbation of asthma attack

• Significant intraoperative hemodynamic instability

• Use of Regional anesthesia techniques